Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology
The DOI matches its Crossref record; 243 of the 243 references it cites were found in a registry or an index.
Abstract
Attention-deficit/hyperactivity disorder (ADHD) is an established diagnosis in children, associated with a large body of evidence on the benefits of treatment. Adolescents with ADHD are now leaving children’s services often with no readily identifiable adult service to support them, which presents problems as local pharmacy regulations often preclude the prescription of stimulant drugs by general practitioners (GPs). In addition, adults with ADHD symptoms are now starting to present to primary care and psychiatry services requesting assessment and treatment. For these reasons, the British Association for Psychopharmacology (BAP) thought it timely to hold a consensus conference to review the body of evidence on childhood ADHD and the growing literature on ADHD in older age groups. Much of this initial guidance on managing ADHD in adolescents in transition and in adults is based on expert opinion derived from childhood evidence. We hope that, by the time these guidelines are updated, much evidence will be available to address the many directions for future research that are detailed here.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recent national guidelines now recommend that ADHD should be recognised and appropriately treated throughout the lifespan [32-34].”
From European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD (2010) · cites this paper as [34]
In the citing paper
“Psychostimulant medications are associated with disrupted or disturbed sleep”
From Associations of sleep disturbance with ADHD: implications for treatment (2015) · cites this paper as Nutt et al. 2007
Citations
Cites
Items 201–243 of 243
Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy
Tan, M. (2005) · Archives of Disease in Childhood · doi:10.1136/adc.2003.048504 · Cited by 90 · cited 1×
“Little research exists in this area, and the research that does exist has studied methylphenidate only (Gross-Tsur et al., 1997; Gucuyener et al., 2003; Tan and Appleton, 2005; van der Feltz-Cornelis and Aldenkamp, 2006).”
BackgroundJESTER, J. M., NIGG, J. T., ADAMS, K., FITZGERALD, H. E., PUTTLER, L. I., WONG, M. M., & ZUCKER, R. A. (2005) · Development and Psychopathology · doi:10.1017/s0954579405050066 · Cited by 88 · cited 1×
“Several studies also suggest that childhood environmental factors shape the phenotypic expression of ADHD, and comorbidity with other behavioural disorders, by acting on genetic influences (e.g. Hudziak et al., 2005; Burt et al., 2005; Dick et al., 2005; Jester et al., 2005 I–II).”
BackgroundMolecular Genetics of Attention
Bellgrove, M. A., & Mattingley, J. B. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1417.013 · Cited by 81
An open trial of venlafaxine in adult patients with attention deficit hyperactivity disorder.
Hedges, D., Reimherr, F. W., Rogers, A., Strong, R. E., & Wender, P. H. (1995) · PubMed · Cited by 81
ALEXANDRA BURT, S., McGUE, M., KRUEGER, R. F., & IACONO, W. G. (2005) · Psychological Medicine · doi:10.1017/s0033291705004770 · Cited by 80 · cited 1×
“Several studies also suggest that childhood environmental factors shape the phenotypic expression of ADHD, and comorbidity with other behavioural disorders, by acting on genetic influences (e.g. Hudziak et al., 2005; Burt et al., 2005; Dick et al., 2005; Jester et al., 2005 I–II).”
BackgroundPaterson, R., Douglas, C., Hallmayer, J., Hagan, M., & Krupenia, Z. (1999) · Australian and New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.1999.00590.x · Cited by 80 · cited 1×
“Similar but more limited findings are reported for dexamfetamine (dextro- or D-amfetamine) (Arnold et al., 1989; Paterson et al., 1999; Taylor and Russo, 2000, 2001 Ib), Adderall mixed amfetamine salts (Spencer et al., 2001; Biederman et al., 2005 Ib), the psychostimulant pemoline (Wilens et al.,…”
ResultNormalized functioning in youths with persistent attention-deficit/hyperactivity disorder
Biederman, J., Mick, E. O., & Faraone, S. V. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70065-4 · Cited by 80 · cited 1×
“…as patients transit through adolescence into adulthood (Hechtman and Weiss, 1983; Barkley et al., 1990; Weiss and Hechtman, 1993; Biederman et al., 1996a; Biederman et al., 1996b; Faraone et al., 1996; Biederman et al., 1998; Mannuzza et al., 1998; Mick et al., 2004; Faraone et al., 2006).”
BackgroundLong-Term Safety and Effectiveness of Mixed Amphetamine Salts Extended Release in Adults With ADHD
Biederman, J., Spencer, T. J., Wilens, T. E., Weisler, R. H., Read, S. C., & Tulloch, S. J. (2005) · CNS Spectrums · doi:10.1017/s1092852900002406 · Cited by 79 · cited 1×
“…D-amfetamine) (Arnold et al., 1989; Paterson et al., 1999; Taylor and Russo, 2000, 2001 Ib), Adderall mixed amfetamine salts (Spencer et al., 2001; Biederman et al., 2005 Ib), the psychostimulant pemoline (Wilens et al., 1999b Ib), and the dopaminergic agent bupropion (Wender and Reimherr, 1990;…”
BackgroundTwelve thousand crimes by 75 boys: A 20-year follow-up study of childhood hyperactivity
Dalteg, A., & Levander, S. E. (1998) · Journal of Forensic Psychiatry · doi:10.1080/09585189808402178 · Cited by 78 · cited 1×
“%) screened as being in partial remission of their symptoms (Eyestone and Howell, 1994; Vitelli, 1995; Dalteg and Levander, 1998 II; Dalteg et al., 1999; Rasmussen et al., 2001; Retz et al., 2004; Rosler et al., 2004).”
BackgroundComorbidity in Adults with Attention‐Deficit/Hyperactivity Disorder
MARKS, D. J., NEWCORN, J. H., & HALPERIN, J. M. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb05781.x · Cited by 77
HYPERACTIVITY IN PRESCHOOL CHILDREN IS HIGHLY HERITABLE
Price, T. S., Simonoff, E. A., Waldman, I. D., Asherson, P. J., & Plomin, R. J. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200112000-00002 · Cited by 76 · cited 1×
“Mathematical modelling using De Fries and Fulker (DF) analysis supports the hypothesis that ADHD is the extreme of behaviours that vary genetically throughout the entire population (Gjone et al., 1996; Levy et al., 1997; Willcutt et al., 2000; Price et al., 2001).”
MethodSelf-citationFerris, R. M., & Tang, F. L. (1979) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)31771-4 · Cited by 73 · cited 1×
“…cross the cell membrane by a mechanism independent of the transporter, and interact with the vesicular monoamine transporter 2 (VMAT2), thereby displacing vesicular dopamine and causing the release of newly synthesized intraneuronal monoamine (Ferris and Tang, 1979; Fleckenstein and Hanson, 2003).”
BackgroundMontgomery, S. A., Bebbington, P., Cowen, P., Deakin, W., Freeling, P., Hallstrom, C., Katona, C., King, D., Leonard, B., Levine, S., et al. (1993) · Journal of Psychopharmacology · doi:10.1177/0269881193007001041 · Cited by 72 · cited 1×
“The association started publishing consensus statements more than a decade ago, and the first BAP guidelines on depression were considered a landmark publication when published in 1993 (Montgomery et al., 1993).”
BackgroundOpen-label trial of venlafaxine in adults with attention deficit disorder.
Adler, L. A., Resnick, S., Kunz, M., & Devinsky, O. (1995) · PubMed · Cited by 72
METHYLPHENDATE AND ADHD: INFLUENCE OF AGE, IQ AND NEURODEVELOPMENTAL STATUS
Mayes, S. D., Crites, D. L., Bixler, E. O., Humphrey, F. J., & Maltison, R. E. (1994) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1994.tb11811.x · Cited by 70
Young, S., Gudjonsson, G., Ball, S., & Lam, J. (2003) · Journal of Forensic Psychiatry & Psychology · doi:10.1080/14789940310001615461 · Cited by 69 · cited 1×
“In one series, 6% of people with personality disorders were screened to have full ADHD symptoms while 29% were in partial remission; the latter was associated with an excess of critical incidents (Young et al., 2003 II).”
BackgroundSelf-citationControlled Trial of High Doses of Pemoline for Adults With Attention-Deficit/Hyperactivity Disorder
Wilens, T. E., Biederman, J., Spencer, T. J., Frazier, J., Prince, J., Bostic, J., Rater, M., Soriano, J., Hatch, M., Sienna, M., et al. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199906000-00009 · Cited by 65 · cited 2×
“…et al., 1989; Paterson et al., 1999; Taylor and Russo, 2000, 2001 Ib), Adderall mixed amfetamine salts (Spencer et al., 2001; Biederman et al., 2005 Ib), the psychostimulant pemoline (Wilens et al., 1999b Ib), and the dopaminergic agent bupropion (Wender and Reimherr, 1990; Wilens et al., 2001 Ib).”
BackgroundKooij, J. J. S., Aeckerlin, L. P., & Buitelaar, J. K. (2001) · PubMed · Cited by 63
Effect of Brief Group Intervention for Adults with Attention Deficit/Hyperactivity Disorder.
Wiggins, D., Singh, K., Hutchins, D. E., & Getz, H. G. (1999) · Journal of Mental Health Counseling · Cited by 58
Clinical Validity and Interpretation of the Gordon Diagnostic System in ADHD Assessments
Dickerson Mayes, S., Calhoun, L., & Crowell, E. W. (2001) · Child Neuropsychology · doi:10.1076/chin.7.1.32.3151 · Cited by 53 · cited 2×
“While little is known about the value of neuropsychological assessment in differential diagnosis in adults and adolescents (Lovejoy et al., 1999) most studies in children reveal that tests of executive function and attention show good positive predictive power but poor negative predictive power (Barkley et al., 1992;…”
BackgroundTraining raters to assess adult ADHD: reliability of ratings
Adler, L. A., Spencer, T., Faraone, S. V., Reimherr, F. W., Kelsey, D., Michelson, D., & Biederman, J. (2005) · Journal of Attention Disorders · doi:10.1177/1087054705277168 · Cited by 51 · cited 3×
“However, effects on overall functioning are debated, while no long-term efficacy trials have yet been reported, although an interim analysis in adults has been reported (Adler et al., 2005a).”
BackgroundMethodThe social anxiety disorder spectrum.
Stein, D. J., Ono, Y., Tajima, O., & Muller, J. E. (2004) · PubMed · Cited by 51
Sonuga-Barke, E. J., Swanson, J. M., Coghill, D., DeCory, H. H., & Hatch, S. J. (2004) · BMC Psychiatry · doi:10.1186/1471-244x-4-28 · Cited by 48 · cited 1×
“…which can be precursors to dependency; in particular, from baseline data of COMACs (Swanson et al., 2004; Sonuga-Barke et al., 2005) and from the titration phase of the MTA (Galanter et al., 2003), in which possible rebound was seen that might be due to tolerance (Sonuga-Barke et al., 2004).”
BackgroundSelf-citationFeltz-Cornelis, C. M. V. D., & Aldenkamp, A. P. (2006) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2006.01.015 · Cited by 46 · cited 1×
“Little research exists in this area, and the research that does exist has studied methylphenidate only (Gross-Tsur et al., 1997; Gucuyener et al., 2003; Tan and Appleton, 2005; van der Feltz-Cornelis and Aldenkamp, 2006).”
BackgroundEffect of nutritional supplements on Attentional-Deficit Hyperactivity Disorder
Dykman, K. D., & Dykman, R. A. (1998) · Integrative Psychological and Behavioral Science · doi:10.1007/bf02688675 · Cited by 46 · cited 1×
“…dietary manipulations can improve ADHD symptoms in at least some children (Egger et al., 1985; Carter et al., 1993; Boris and Mandel, 1994; Rowe and Rowe, 1994; Schmidt et al., 1997; Dykman and Dykman, 1998; Richardson and Puri, 2002 Ib), although the mechanism of these improvements is unknown.”
BackgroundSeager, M. C., & O'Brien, G. (2003) · Journal of Intellectual Disability Research · doi:10.1046/j.1365-2788.47.s1.30.x · Cited by 45
Asherson, P., Kuntsi, J., & Taylor, E. (2005) · British Journal of Psychiatry · doi:10.1192/bjp.187.2.103 · Cited by 45 · cited 3×
“Several genes have been reported to be associated with ADHD in multiple studies, with small but significant effects confirmed by meta-analysis (Asherson et al., 2005; Faraone et al., 2005b, Thapar et al., 2005a).”
BackgroundSelf-citationPemoline hepatotoxicity in children
Marotta, P. J., & Roberts, E. A. (1998) · The Journal of Pediatrics · doi:10.1016/s0022-3476(98)70329-4 · Cited by 45 · cited 1×
“However, pemoline is associated with hepatotoxicity (Marotta and Roberts, 1998 III) and has been withdrawn from use.”
BackgroundVitelli, R. (1996) · International Journal of Offender Therapy and Comparative Criminology · doi:10.1177/0306624x96404002 · Cited by 38 · cited 1×
“In adulthood, some 30–50% are screened as possibly being fully symptomatic, with a high proportion of inmates (15–50%) screened as being in partial remission of their symptoms (Eyestone and Howell, 1994; Vitelli, 1995; Dalteg and Levander, 1998 II; Dalteg et al., 1999; Rasmussen et al., 2001; Retz et al., 2004; Rosler…”
BackgroundGehlert, D. R., Schober, D. A., Hemrick-Luecke, S. K., Krushinski, J. H., Howbert, J. J., Robertson, D. W., Fuller, R. W., & Wong, D. T. (1995) · Neurochemistry International · doi:10.1016/0197-0186(94)00113-9 · Cited by 37 · cited 1×
“Atomoxetine is a relatively selective NET inhibitor, having approximately a 300-fold higher affinity for NET than DAT, (Thomason and Michelson, 2004; Gehlert et al., 1995).”
BackgroundThe Use of Antidepressants to Treat Attention Deficit Hyperactivity Disorder in Adults
Maidment, I. (2003) · Journal of Psychopharmacology · doi:10.1177/02698811030173016 · Cited by 35 · cited 3×
“The drugs of first choice for the treatment of adult ADHD are classified as either psychostimulants (e.g. methylphenidate, amfetamines (Maidment, 2003a)) or non-stimulant (e.g. atomoxetine (Thomason and Michelson, 2004)) (see Table 3).”
BackgroundThe adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorder
Ashton, H., Gallagher, P., & Moore, B. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106061710 · Cited by 31 · cited 1×
“Various concerns have been raised over long-term treatment effects, including the potential for tolerance over time, and adverse effects of psychostimulants such as psychosis, sensitization, dependency and withdrawal reactions (Ashton et al., 2006).”
BackgroundGudjonsson, G. H., & Young, S. (2006) · Legal and Criminological Psychology · doi:10.1348/135532505x58954 · Cited by 30
Self-citationDalteg, A., Lindgren, M., & Levander, S. E. (1999) · Journal of Forensic Psychiatry · doi:10.1080/09585189908402163 · Cited by 28 · cited 1×
“%) screened as being in partial remission of their symptoms (Eyestone and Howell, 1994; Vitelli, 1995; Dalteg and Levander, 1998 II; Dalteg et al., 1999; Rasmussen et al., 2001; Retz et al., 2004; Rosler et al., 2004).”
BackgroundRielly, N. E., Cunningham, C. E., Richards, J. E., Elbard, H., & Mahoney, W. J. (1999) · Journal of Clinical and Experimental Neuropsychology · doi:10.1076/jcen.21.5.685.866 · Cited by 27 · cited 1×
“…reveal that tests of executive function and attention show good positive predictive power but poor negative predictive power (Barkley et al., 1992; Sharma et al., 1991; Grodzinsky and Barkley, 1999; Rielly et al., 1999; Doyle et al., 2000; Dickerson Mayes et al., 2001; Berlin et al., 2004).”
BackgroundAtomoxetine - Treatment of attention deficit hyperactivity disorder: Beyond stimulants
Thomason, C., & Michelson, D. J. (2004) · Drugs of today · doi:10.1358/dot.2004.40.5.850493 · Cited by 20 · cited 6×
“Atomoxetine is a relatively selective NET inhibitor, having approximately a 300-fold higher affinity for NET than DAT, (Thomason and Michelson, 2004; Gehlert et al., 1995).”
BackgroundResultInfluentialPost, R. M., Chang, K., Findling, R. L., Geller, B., Kowatch, R. A., Kutcher, S., & Leverich, G. S. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0703 · Cited by 16 · cited 1×
“In Europe, bipolar disorder is a controversial diagnosis alongside a diagnosis of ADHD in childhood, and yet experts in other areas recognize that children with unstable mood and ADHD symptoms do exist (Geller et al., 2000a, 2000b; Craney and Geller, 2003; Post et al., 2004).”
BackgroundTHE DIMENSION OF FOCUSSED ATTENTION: RELATIONSHIP TO BEHAVIOR AND COGNITIVE FUNCTIONING IN CHILDREN
Sharma, V., Newcorn, J. H., Halperin, J. H., & Wolf, L. E. (1991) · Perceptual and Motor Skills · doi:10.2466/pms.1991.72.3.787 · Cited by 15 · cited 2×
“, 1999) most studies in children reveal that tests of executive function and attention show good positive predictive power but poor negative predictive power (Barkley et al., 1992; Sharma et al., 1991; Grodzinsky and Barkley, 1999; Rielly et al., 1999; Doyle et al., 2000; Dickerson Mayes et al., 2001; Berlin et al., 2…”
BackgroundEfficacy of Stimulants in Adult ADHD
Maidment, I. D. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1d028 · Cited by 12 · cited 3×
“The drugs of first choice for the treatment of adult ADHD are classified as either psychostimulants (e.g. methylphenidate, amfetamines (Maidment, 2003a)) or non-stimulant (e.g. atomoxetine (Thomason and Michelson, 2004)) (see Table 3).”
BackgroundSonuga-Barke, E. J. S., Elgie, S., & Hall, M. (2005) · Behavioral and Brain Functions · doi:10.1186/1744-9081-1-10 · Cited by 12
Self-citationSafren, S. A., Sprich, S. E., Perlman, C. A., & Otto, M. W. (2017) · doi:10.1093/med:psych/9780190235567.001.0001 · Cited by 10
Young, S., & Harty, M. A. (2001) · Journal of Forensic Psychiatry · doi:10.1080/09585180010027905 · Cited by 9 · cited 1×
“• What are the legal implications of a diagnosis of ADHD? been shown to markedly improve symptoms and functioning, and thus improve ability to access other services in a severely affected individual (Young and Harty, 2001 III).”
BackgroundSelf-citationGuideline 4: Medication Treatment: General Principles
(2000) · American Journal on Mental Retardation · doi:10.1352/0895-8017(2000)105<0178:gmtgp>2.0.co;2 · Cited by 4
Research works printed but not linked: 20
- Alsop M (2005) Equality in Justice, ADHD Across the Lifespan. Dorset ADHD Support Group, Weymouth (www.dorsetadhd.org.uk)
- American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders version IV text revision. American Psychiatric Association, Washington DC
- 10.1177/026988110001400101 · DOI · Paper page
- 10.1111/1469-7610.00452 · doi:10.1111/1469-7610.00452 · Paper page
- Biederman J , Spencer T J (2001) Psychopharmacology of adults with attention-deficit/hyperactivity disorder . Primary Psychiatry 11: 57-62
- Bloom B , Dey A N (2004) Summary health statistics for U.S. children: National Health Interview Survey . Vital Health Stat 10: 1-85
- Brassett-Grundy A , Butler N (2004a) Attention-Deficit/Hyperactivity Disorder: An overview and review of the literature relating to the correlates and lifecourse outcomes for males and females. Bedford Group for Lifecourse and Statistical Studies Occasional Paper: No. 1. Institute of Education, University of London
- Brassett-Grundy A , Butler N (2004b) Prevalence and Adult Outcomes of Attention-Deficit/Hyperactivity Disorder: Evidence from a 30-year prospective longitudinal study. Bedford Group for Lifecourse and Statistical Studies Occasional Paper: No. 2. Institute of Education, University of London
- Coghill D (2006) Making the most of scant resources. In Yule W (ed.), The ADHD Spectrum. ACAMH Occasional papers 24, ACAMH, London
- Conners C K , Erhardt D , Sparrow E , Conners M A (1998) CAARS Adult ADHD Rating Scales. Multi Health Systems Inc., New York
- Gadow K , Sprafkin J , Weiss M (1999) Adult Inventories-4. Available at: www.checkmateplus.com
- 10.1037/0003-066X.43.10.786 · doi:10.1037/0003-066x.43.10.786 · Paper page
- 10.1080/j.1440-1614.1999.00590.x · doi:10.1080/j.1440-1614.1999.00590.x · Paper page
- Ward M F , Wender P H , Reimherr F W (1993) The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder . Am J Psychiatry 150: 885-890 .
- Weiss M D , Murray C (2004) Practice Guideline for the Assessment of ADHD in adults. Canadian ADHD Resource Alliance, Vancouver, Canada
- WHO (1992) The ICD-10 classification of mental and behavioural disorders. Geneva, Switzerland
- World Health Organization (1992) The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. World Health Organization, Geneva
- Young S J , Gudjonsson G (submitted) Growing out of attention-deficit/hyperactivity disorder: the relationship between functioning and symptoms
- Young S J , Ross R R (2006) R&R2 for ADHD youth and adults. A handbook for teaching prosocial competence. Cognitive Centre of Canada, Ottawa (cogcen@canada.com)
- Young S J , Ross R R (in preparation) R&R2 for ADHD children. A handbook for teaching prosocial competence
Cited by
Kooij, S. J., Bejerot, S., Blackwell, A., Caci, H., Casas-Brugué, M., Carpentier, P. J., Edvinsson, D., Fayyad, J., Foeken, K., Fitzgerald, M., et al. (2010) · BMC Psychiatry · doi:10.1186/1471-244x-10-67 · Cited by 928
“now recommend that ADHD should be recognised and appropriately treated throughout the lifespan [32-34].”
Self-citationShaw, M., Hodgkins, P., Caci, H., Young, S., Kahle, J., Woods, A. G., & Arnold, L. E. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-99 · Cited by 759
“Several of these organizations recognize a need for further study of the long-term consequences of ADHD and of its treatment [22,29,30,32,33].”
BackgroundSelf-citationUpdated European Consensus Statement on diagnosis and treatment of adult ADHD
Kooij, J. J. S., Bijlenga, D., Salerno, L., Jaeschke, R., Bitter, I., Balázs, J., Thome, J., Dom, G., Kasper, S., Nunes Filipe, C., et al. (2019) · European Psychiatry · doi:10.1016/j.eurpsy.2018.11.001 · Cited by 686
Self-citationLive fast, die young? A review on the developmental trajectories of ADHD across the lifespan
Franke, B., Michelini, G., Asherson, P., Banaschewski, T., Bilbow, A., Buitelaar, J. K., Cormand, B., Faraone, S. V., Ginsberg, Y., Haavik, J., et al. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.08.001 · Cited by 643
Self-citationWilson, S., Nutt, D., Alford, C., Argyropoulos, S., Baldwin, D., Bateson, A., Britton, T., Crowe, C., Dijk, D.-J., Espie, C., et al. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110379307 · Cited by 634
Self-citation
Metadata
- Authors
- Nutt, D. J., Fone, K., Asherson, P., Bramble, D., Hill, P., Matthews, K., Morris, K. A., Santosh, P., Sonuga-Barke, E., Taylor, E., Weiss, M., & Young, S.
- Affiliations
- University of Bristol (GB)
- University of Nottingham (GB)
- King's College London (GB)
- Telford & Wrekin PCT, Shrewsbury, UK
- London, UK
- University of Dundee (GB)
- Institute of Psychiatry, London, UK
- University of Southampton (GB)
- University of British Columbia (CA)
- Bethlem Royal Hospital (GB)
- Corresponding author
- Nutt, D. J.
- ORCID
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2007-01
- Volume
- 21
- Issue
- 1
- Pages
- 10-41
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2006463161
- Semantic Scholar
- 601bde001c8005e8fae1acf04b12ce0b33b7db90
- Cited by
- 259
- References
- 242
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 6 · 2023: 4 · 2022: 4 · 2021: 10 · 2020: 8 · 2019: 5 · 2018: 8 · 2017: 12 · 2016: 13 · 2015: 12 · 2014: 28 · 2013: 28 · 2012: 37
- FWCI
- 10.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Adolescent and Pediatric Healthcare
- Keywords
- attention deficit hyperactivity disorder, adult ADHD, adolescents, transition to adult services, stimulant medication, psychopharmacological treatment, primary care, consensus recommendations
- MeSH terms
- Adolescent, Adult, Age Factors, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, United Kingdom, Health Services Needs and Demand, Humans, Mental Health Services, Primary Health Care, Psychiatric Status Rating Scales, Comorbidity, Adolescent Health Services, Models, Organizational, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.